Matches in Nanopublications for { ?s ?p "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP641544.RArd6Mjsx-_NWiDjFAqVT_9fOkoJAMxNG4RAFRZNfiJ6I130_assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641544.RArd6Mjsx-_NWiDjFAqVT_9fOkoJAMxNG4RAFRZNfiJ6I130_provenance.
- assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP532152.RAR9pXQjJMNoeoNvHfa4PjRbDbaMPZ2OnfN0mu4S6qc2o130_assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532152.RAR9pXQjJMNoeoNvHfa4PjRbDbaMPZ2OnfN0mu4S6qc2o130_provenance.
- NP594876.RALFnfPQut1LJZKJEk6A1nIQc8tja9WyfqLiLugCmv4Ys130_assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594876.RALFnfPQut1LJZKJEk6A1nIQc8tja9WyfqLiLugCmv4Ys130_provenance.
- assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP797223.RAXsqVs6PzObvvgJ2g_snDIlUP0g6jh8pcqVfe20t7mIw130_assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797223.RAXsqVs6PzObvvgJ2g_snDIlUP0g6jh8pcqVfe20t7mIw130_provenance.
- NP797224.RARjnocn9VmipDvYRGb8-sL0KmWrQ2BB5uq9oecAwrTbM130_assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797224.RARjnocn9VmipDvYRGb8-sL0KmWrQ2BB5uq9oecAwrTbM130_provenance.
- NP307858.RAx2IcfmsJHKjRM4HpRHD806kmC8I1Zz1mbdUPz5KAInY130_assertion description "[In the attempt to find alternative therapeutic regimes for such patients, we tested PHA-848125, an oral pan cyclin-dependent kinase inhibitor currently under evaluation in phase II clinical trial, on a transgenic mouse model, K-Ras(G12D)LA2, which develops pulmonary cancerous lesions reminiscent of human lung adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307858.RAx2IcfmsJHKjRM4HpRHD806kmC8I1Zz1mbdUPz5KAInY130_provenance.